Currently holds a position at Novavax Inc
Position | Company | Period |
---|---|---|
President, Research and Development | Novavax Inc | March 1, 2016 - |
Senior Vice President - Research & Development | Novavax Inc | Jan. 13, 2014 - March 1, 2016 |
Senior Vice President, Chief Medical Officer | Novavax Inc | Jan. 1, 2011 - Jan. 13, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-03-14 | 2023-03-06 |
Novavax Inc
(NVAX)
|
PP Planned purchase |
3,000
+35.4%
7.4822,454 USD |
3,000 +35.4% | 7.48 | 22,454 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
27
-0.5%
180.624,877 USD |
27 -0.5% | 180.62 | 4,877 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
206
-3.5%
179.5836,993 USD |
206 -3.5% | 179.58 | 36,993 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
103
-1.7%
178.9918,436 USD |
103 -1.7% | 178.99 | 18,436 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
223
-3.6%
176.8339,432 USD |
223 -3.6% | 176.83 | 39,432 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
67
-1.1%
175.8911,785 USD |
67 -1.1% | 175.89 | 11,785 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
137
-2.1%
174.6523,927 USD |
137 -2.1% | 174.65 | 23,927 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
91
-1.4%
173.2915,770 USD |
91 -1.4% | 173.29 | 15,770 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
248
-3.7%
172.3842,750 USD |
248 -3.7% | 172.38 | 42,750 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
254
-3.6%
171.4743,553 USD |
254 -3.6% | 171.47 | 43,553 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
213
-2.9%
170.4636,309 USD |
213 -2.9% | 170.46 | 36,309 USD | |
2021-12-16 | 2021-12-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
117
-1.6%
168.8219,752 USD |
117 -1.6% | 168.82 | 19,752 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-2.4%
182.9618,296 USD |
100 -2.4% | 182.96 | 18,296 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
853
-17.0%
182.30155,498 USD |
853 -17.0% | 182.30 | 155,498 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-9.1%
180.2990,147 USD |
500 -9.1% | 180.29 | 90,147 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-8.3%
179.3689,680 USD |
500 -8.3% | 179.36 | 89,680 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-7.7%
178.2189,104 USD |
500 -7.7% | 178.21 | 89,104 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
800
-10.9%
176.20140,956 USD |
800 -10.9% | 176.20 | 140,956 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
900
-11.0%
175.13157,619 USD |
900 -11.0% | 175.13 | 157,619 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-2.4%
173.1434,627 USD |
200 -2.4% | 173.14 | 34,627 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-2.3%
171.3034,260 USD |
200 -2.3% | 171.30 | 34,260 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
400
-4.4%
168.7767,508 USD |
400 -4.4% | 168.77 | 67,508 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-3.2%
167.0650,118 USD |
300 -3.2% | 167.06 | 50,118 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-3.1%
165.8049,739 USD |
300 -3.1% | 165.80 | 49,739 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-3.0%
164.7749,430 USD |
300 -3.0% | 164.77 | 49,430 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-2.0%
162.8332,565 USD |
200 -2.0% | 162.83 | 32,565 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-2.9%
161.6348,490 USD |
300 -2.9% | 161.63 | 48,490 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-2.8%
160.5248,157 USD |
300 -2.8% | 160.52 | 48,157 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-2.7%
158.4247,527 USD |
300 -2.7% | 158.42 | 47,527 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-1.8%
157.0231,404 USD |
200 -1.8% | 157.02 | 31,404 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
300
-2.6%
156.2446,873 USD |
300 -2.6% | 156.24 | 46,873 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-0.9%
154.3815,438 USD |
100 -0.9% | 154.38 | 15,438 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
397
-3.3%
153.5360,951 USD |
397 -3.3% | 153.53 | 60,951 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-0.8%
151.8515,185 USD |
100 -0.8% | 151.85 | 15,185 USD | |
2021-12-09 | 2021-12-07 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-1.6%
150.3030,059 USD |
200 -1.6% | 150.30 | 30,059 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-2.4%
211.7521,175 USD |
100 -2.4% | 211.75 | 21,175 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
551
-11.7%
210.57116,026 USD |
551 -11.7% | 210.57 | 116,026 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
879
-15.7%
209.81184,419 USD |
879 -15.7% | 209.81 | 184,419 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,450
-20.6%
208.78302,727 USD |
1,450 -20.6% | 208.78 | 302,727 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
353
-4.8%
207.1973,139 USD |
353 -4.8% | 207.19 | 73,139 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
439
-5.6%
206.0690,462 USD |
439 -5.6% | 206.06 | 90,462 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
465
-5.6%
203.7994,764 USD |
465 -5.6% | 203.79 | 94,764 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
715
-7.9%
202.37144,692 USD |
715 -7.9% | 202.37 | 144,692 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
338
-3.6%
201.2368,015 USD |
338 -3.6% | 201.23 | 68,015 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
717
-7.1%
200.40143,690 USD |
717 -7.1% | 200.40 | 143,690 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
678
-6.3%
199.25135,091 USD |
678 -6.3% | 199.25 | 135,091 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
836
-7.2%
198.17165,670 USD |
836 -7.2% | 198.17 | 165,670 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
356
-3.0%
197.3170,242 USD |
356 -3.0% | 197.31 | 70,242 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
518
-4.2%
195.87101,460 USD |
518 -4.2% | 195.87 | 101,460 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-1.6%
194.6238,923 USD |
200 -1.6% | 194.62 | 38,923 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
222
-1.7%
192.5842,752 USD |
222 -1.7% | 192.58 | 42,752 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
4
-0.0%
191.29765 USD |
4 -0.0% | 191.29 | 765 USD | |
2021-12-02 | 2021-11-30 |
Novavax Inc
(NVAX)
|
PS Planned sale |
121
-0.9%
189.9822,987 USD |
121 -0.9% | 189.98 | 22,987 USD | |
2021-11-30 | 2021-11-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
114
-2.7%
221.2425,222 USD |
114 -2.7% | 221.24 | 25,222 USD | |
2021-11-30 | 2021-11-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
155
-3.6%
220.2234,134 USD |
155 -3.6% | 220.22 | 34,134 USD | |
2021-11-30 | 2021-11-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
412
-8.7%
219.2590,333 USD |
412 -8.7% | 219.25 | 90,333 USD | |
2021-11-30 | 2021-11-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
626
-11.7%
218.25136,627 USD |
626 -11.7% | 218.25 | 136,627 USD | |
2021-11-30 | 2021-11-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
331
-5.8%
217.3671,946 USD |
331 -5.8% | 217.36 | 71,946 USD | |
2021-11-30 | 2021-11-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
260
-4.4%
216.1956,209 USD |
260 -4.4% | 216.19 | 56,209 USD | |
2021-11-30 | 2021-11-26 |
Novavax Inc
(NVAX)
|
PS Planned sale |
185
-3.0%
215.0039,776 USD |
185 -3.0% | 215.00 | 39,776 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
200
-4.7%
203.6240,723 USD |
200 -4.7% | 203.62 | 40,723 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
870
-17.0%
202.65176,302 USD |
870 -17.0% | 202.65 | 176,302 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
722
-12.3%
201.48145,468 USD |
722 -12.3% | 201.48 | 145,468 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,600
-21.5%
200.55320,887 USD |
1,600 -21.5% | 200.55 | 320,887 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,387
-15.7%
199.51276,720 USD |
1,387 -15.7% | 199.51 | 276,720 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,271
-12.6%
198.47252,252 USD |
1,271 -12.6% | 198.47 | 252,252 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,400
-12.2%
197.44276,419 USD |
1,400 -12.2% | 197.44 | 276,419 USD | |
2021-11-24 | 2021-11-23 |
Novavax Inc
(NVAX)
|
PS Planned sale |
800
-6.5%
196.43157,143 USD |
800 -6.5% | 196.43 | 157,143 USD | |
2021-11-17 | 2021-11-16 |
Novavax Inc
(NVAX)
|
PS Planned sale |
600
-12.9%
170.94102,562 USD |
600 -12.9% | 170.94 | 102,562 USD | |
2021-11-17 | 2021-11-16 |
Novavax Inc
(NVAX)
|
PS Planned sale |
4,352
-48.3%
170.26740,977 USD |
4,352 -48.3% | 170.26 | 740,977 USD | |
2021-11-17 | 2021-11-16 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,326
-12.8%
168.91223,969 USD |
1,326 -12.8% | 168.91 | 223,969 USD | |
2021-11-17 | 2021-11-16 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,472
-12.5%
167.95247,225 USD |
1,472 -12.5% | 167.95 | 247,225 USD | |
2021-11-17 | 2021-11-16 |
Novavax Inc
(NVAX)
|
PS Planned sale |
500
-4.1%
166.8983,446 USD |
500 -4.1% | 166.89 | 83,446 USD | |
2021-11-17 | 2021-11-15 |
Novavax Inc
(NVAX)
|
PS Planned sale |
1,183
-22.6%
172.02203,496 USD |
1,183 -22.6% | 172.02 | 203,496 USD | |
2021-11-12 | 2021-11-09 |
Novavax Inc
(NVAX)
|
PS Planned sale |
100
-2.4%
171.4817,148 USD |
100 -2.4% | 171.48 | 17,148 USD |